当前位置:首页 - 行情中心 - 港通医疗(301515) - 财务分析 - 现金流量表

港通医疗

(301515)

  

流通市值:14.64亿  总市值:23.22亿
流通股本:6304.16万   总股本:1.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金437,452,721.74284,306,850.46138,755,526.69717,926,516.9
  收到的税费返还0---
  收到其他与经营活动有关的现金17,540,909.2514,132,037.719,185,466.4721,933,874.96
  经营活动现金流入小计454,993,630.99298,438,888.17147,940,993.16739,860,391.86
  购买商品、接受劳务支付的现金316,823,205.21199,917,795.2694,584,672.02490,850,349.35
  支付给职工以及为职工支付的现金101,273,513.2454,937,930.1728,870,595.08143,468,816.15
  支付的各项税费33,715,632.2523,688,507.9814,646,216.7254,079,681.63
  支付其他与经营活动有关的现金85,293,948.1359,043,674.4424,930,484.6262,405,434.64
  经营活动现金流出小计537,106,298.83337,587,907.85163,031,968.44750,804,281.77
  经营活动产生的现金流量净额-82,112,667.84-39,149,019.68-15,090,975.28-10,943,889.91
二、投资活动产生的现金流量:
  收回投资收到的现金326,000,000326,000,00080,000,000372,000,000
  取得投资收益收到的现金0---
  处置固定资产、无形资产和其他长期资产收回的现金净额0---
  处置子公司及其他营业单位收到的现金净额0---
  收到的其他与投资活动有关的现金4,359,032.534,359,032.531,292,444.4412,727,807.37
  投资活动现金流入小计330,359,032.53330,359,032.5381,292,444.44384,727,807.37
  购建固定资产、无形资产和其他长期资产支付的现金15,375,867.548,456,996.524,512,870.3836,998,822.6
  投资支付的现金653,250,000193,250,000191,000,000416,000,000
  取得子公司及其他营业单位支付的现金0---
  支付其他与投资活动有关的现金0---
  投资活动现金流出小计668,625,867.54201,706,996.52195,512,870.38452,998,822.6
  投资活动产生的现金流量净额-338,266,835.01128,652,036.01-114,220,425.94-68,271,015.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,000,0001,000,000--
  其中:子公司吸收少数股东投资收到的现金1,000,000---
  取得借款收到的现金221,000,000105,000,00096,000,000225,200,000
  收到其他与筹资活动有关的现金7,271,502.676,977,971.425,991,904.7552,686,242.3
  筹资活动现金流入小计229,271,502.67112,977,971.42101,991,904.75277,886,242.3
  偿还债务支付的现金94,800,00032,800,00011,000,000184,200,000
  分配股利、利润或偿付利息支付的现金14,475,266.62,728,837.441,245,667.4840,550,525.45
  支付其他与筹资活动有关的现金76,337,158.0567,972,560.8349,642,848.0938,319,916.91
  筹资活动现金流出小计185,612,424.65103,501,398.2761,888,515.57263,070,442.36
  筹资活动产生的现金流量净额43,659,078.029,476,573.1540,103,389.1814,815,799.94
四、汇率变动对现金及现金等价物的影响-6,553.19-1,778.53-185.448,752.18
五、现金及现金等价物净增加额-376,726,978.0298,977,810.95-89,208,197.48-64,390,353.02
  加:期初现金及现金等价物余额575,872,145.5575,872,145.5575,872,145.5640,262,498.52
  期末现金及现金等价物余额199,145,167.48674,849,956.45486,663,948.02575,872,145.5
补充资料:
  净利润--9,141,458.61-14,421,866.44
  资产减值准备-21,268,758.86-48,421,782.84
  固定资产和投资性房地产折旧-3,173,640.92-4,830,279.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,173,640.92-4,830,279.83
  无形资产摊销-495,016.71-1,083,335.34
  长期待摊费用摊销-356,897.36-670,688.38
  处置固定资产、无形资产和其他长期资产的损失--114,157.19--75,411.84
  固定资产报废损失-52,829.6-59,330.64
  公允价值变动损失--511,856.85--957,316.41
  财务费用-3,249,072.91--5,175,679.13
  递延所得税--3,991,655--8,798,542.32
  其中:递延所得税资产减少--3,734,197.71--8,287,532.76
    递延所得税负债增加--257,457.29--511,009.56
  存货的减少--29,013,260.28-90,872,163.85
  经营性应收项目的减少--61,157,784.26--71,797,076.69
  经营性应付项目的增加-33,377,759.14--94,072,190.26
  其他---3,270,120.23
  融资租入固定资产---2,749,992.25
  现金的期末余额-674,849,956.45-575,872,145.5
  减:现金的期初余额-575,872,145.5-640,262,498.52
  现金及现金等价物的净增加额-98,977,810.95--64,390,353.02
公告日期2025-10-302025-08-292025-04-212025-04-21
审计意见(境内)标准无保留意见
TOP↑